Fourth Dimension Wealth LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Fourth Dimension Wealth LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 51 shares of the biotechnology company’s stock, valued at approximately $30,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. New Wave Wealth Advisors LLC acquired a new stake in Axon Enterprise in the fourth quarter worth $40,000. Y.D. More Investments Ltd bought a new stake in Axon Enterprise during the 4th quarter worth about $45,000. Elequin Capital LP acquired a new position in Axon Enterprise during the fourth quarter valued at approximately $46,000. Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $53,000. Finally, GPS Wealth Strategies Group LLC grew its position in shares of Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after acquiring an additional 40 shares during the period. Institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In related news, President Joshua Isner sold 9,905 shares of the business’s stock in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $738.03, for a total value of $7,310,187.15. Following the completion of the sale, the president now directly owns 298,809 shares of the company’s stock, valued at $220,530,006.27. The trade was a 3.21% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,969 shares of company stock worth $23,127,314. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $731.37 on Friday. The stock has a market cap of $56.94 billion, a price-to-earnings ratio of 188.98, a P/E/G ratio of 5.17 and a beta of 1.24. The company’s fifty day moving average is $603.25 and its 200 day moving average is $604.88. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $748.80.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company had revenue of $603.63 million during the quarter, compared to analysts’ expectations of $585.67 million. During the same period in the prior year, the company posted $1.15 earnings per share. Axon Enterprise’s revenue for the quarter was up 31.3% compared to the same quarter last year. Sell-side analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently commented on AXON shares. The Goldman Sachs Group lifted their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research note on Wednesday, May 14th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Needham & Company LLC increased their target price on Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday, May 8th. Barclays lifted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a research note on Friday, May 9th. Finally, Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $652.73.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.